#Mexico #Laval #Bausch Health #YUN #Probiotherapy

Bausch Health and YUN: A New Era of Skin Care Expansion

In an exciting development for the dermatological landscape, Bausch Health Companies Inc. has partnered with YUN, a Belgian innovator in microbiome-based products, to expand their strategic operations into Mexico and other markets across the EMEA region. This collaboration aims to enhance access to scientific, microbiome-friendly skincare solutions, as reflected in their recent initiatives.

Expansion Overview

The partnership marks a significant growth phase after Bausch Health launched YUN's skincare solutions in Poland in 2025, focusing initially on products beneficial for acne-prone skin. Recently, the collaboration has broadened its geographic reach and product offerings, introducing YUN’s therapies for eczema-prone skin. As a result, these innovative skincare solutions are now entering markets in the Czech Republic, Slovakia, Ukraine, and Bulgaria, with plans for Kazakhstan set to unfold in October 2026.

Cees Heiman, Senior Vice President of Europe and Canada at Bausch Health, emphasized the mutual ambition between both companies to provide state-of-the-art health and skincare solutions to patients and consumers throughout the EMEA region. The commitment to increasing the availability of microbiome-focused therapies is a defining feature of this strategy, showcasing the potential for growth in markets like Ukraine and Bulgaria.

Significance of the Mexican Market

Fernando Zarate, Vice President of Latin America at Bausch Health, articulated the importance of the Mexican market, pointing out that it represents a tremendous opportunity to extend their dermatological portfolio with research-backed solutions. The targeted launch is not merely an expansion; it aligns with the evolving needs of consumers seeking effective and innovative skincare products.

The introduction of these specialized products in Mexico embodies Bausch Health’s dedication to improving healthcare and skincare accessibility, contributing positively to the Mexican market landscape.

Innovative Product Solutions by YUN

YUN is recognized for its groundbreaking YUN Probiotherapy™, which centers around the integration of live probiotics into skincare formulations. These products are developed with the aim of supporting the skin’s natural ecosystem while respecting its delicate balance. Tom Verlinden, CEO and founder of YUN, expressed pride in furthering their partnership with Bausch Health, seeing the expansion into international markets as vital to fulfilling their mission.

By employing scientific principles grounded in microbiome research, YUN continuously innovates in various areas, including dermatological care and intimate health, with solutions that honor and support the body’s natural equilibrium.

Future Outlook

Bausch Health and YUN’s ongoing partnership symbolizes a strategic pivot to ensure wide-reaching access to high-quality, scientifically-validated skincare products. With a focus on promoting better health outcomes across various populations, both companies aim to pave the way for future growth and collaboration in emerging markets.

As the rollout progresses in Kazakhstan and further EMEA regions, the collaborative efforts are firmly rooted in a goal to enrich the lives of individuals by providing natural and effective skincare solutions.

For further information regarding Bausch Health and YUN, please visit their respective websites: Bausch Health and YUN Probiotherapy.